Document Detail


No cardiovascular effects of single-dose pseudoephedrine in patients with essential hypertension treated with beta-blockers.
MedLine Citation:
PMID:  10424315     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The use of the decongestant pseudoephedrine has been cautioned in patients with arterial hypertension, due to the possible rise in blood pressure induced by the sympathostimulatory properties of the drug. This effect could be enhanced in hypertensives treated with beta-blockers, in whom the vasoconstrictor effect of alpha-adrenergic stimulation is unbalanced. The purpose of this study was to investigate the cardiovascular response to pseudoephedrine in hypertensive patients treated with different types of beta-blockers. METHODS: We recruited 29 (18 males) mild-to-moderate essential hypertensive patients [mean age 49(2) years] in a randomized, placebo-controlled, crossover trial. All participants received either placebo, or a nonselective (propranolol 160 mg once daily) or a selective (atenolol 100 mg once daily) beta-blocker for 1 week. At the end of each period, all patients received a single oral dose of pseudoephedrine (60 mg) and their blood pressure and heart rate were monitored at repeated intervals for 2 h. RESULTS: After 1 week of propranolol or atenolol, patients had significantly lower systolic blood pressure and heart rate than after placebo, whereas diastolic blood pressure was not significantly modified. The acute administration of pseudoephedrine did not change systolic and diastolic blood pressure and heart rate from baseline at the end of any of the treatment periods. CONCLUSIONS: A standard oral dose of pseudoephedrine does not significantly affect blood pressure values in hypertensive patients treated with beta-blockers, and therefore may be safely used in this subset of patients.
Authors:
N Mores; U Campia; P Navarra; C Cardillo; P Preziosi
Related Documents :
6894165 - Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephri...
6206325 - Correlation between lymphocyte beta 2-adrenoceptor density and mean arterial blood pres...
1350485 - Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and ...
10552685 - Paprika (capsicum annuum) oleoresin extraction with supercritical carbon dioxide.
8575555 - Induction of neovascularization in vivo by glycerol.
17188375 - Reactive hyperemic pre-ejection shear stress of brachial artery determines endothelial ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  55     ISSN:  0031-6970     ISO Abbreviation:  Eur. J. Clin. Pharmacol.     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-09-08     Completed Date:  1999-09-08     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  251-4     Citation Subset:  IM    
Affiliation:
Istituto di Farmacologia, Università Cattolica del Sacro Cuore, Rome, Italy. nmores@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Agonists / adverse effects*,  therapeutic use
Adrenergic beta-Antagonists / adverse effects*,  therapeutic use
Antihypertensive Agents / adverse effects*,  therapeutic use
Blood Pressure / drug effects
Cross-Over Studies
Ephedrine / adverse effects*,  therapeutic use
Female
Heart Rate / drug effects
Hemodynamics / drug effects*
Humans
Hypertension / drug therapy*,  physiopathology
Male
Middle Aged
Single-Blind Method
Vasoconstrictor Agents / adverse effects*,  therapeutic use
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 0/Adrenergic beta-Antagonists; 0/Antihypertensive Agents; 0/Vasoconstrictor Agents; 299-42-3/Ephedrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effectiveness, safety and epidemiology of the use of acarbose in the treatment of patients with ...
Next Document:  Effects of captopril and enalapril on electroencephalogram and cognitive performance in healthy volu...